Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Procaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A known ✓ | P35498 | 5/20 | 0.68 |
| ▸ | SCN2A known ✓ | Q99250 | 5/20 | 0.68 |
| ▸ | SCN3A known ✓ | Q9NY46 | 5/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 5/20 | 1.00 |
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 1.00 |
| ▸ | HTR3A | P46098 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 0.97 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.97 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 6/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.67 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | DRD3 | P35462 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procaine SCHEMBL28977033 | 0.98 | CYP2D6 (0.97) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL3422994 | 0.98 | CYP2D6 (0.97) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL11047275 | 0.98 | CYP2D6 (0.97) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL3731588 | 0.98 | BLM (1.00) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL5311049 | 0.98 | BLM (1.00) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL6901191 | 0.98 | BLM (1.00) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL27720 | 0.98 | BLM (1.00) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL9050778 | 0.98 | CYP2D6 (0.97) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL6061234 | 0.98 | CYP2D6 (0.97) | CYP2D6TSHRMAOAHRH3HTR3A | |
| Procaine SCHEMBL8533022 | 0.98 | BLM (1.00) | CYP2D6TSHRMAOAHRH3HTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 176082 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-28 | — | — | US | claimed |
| EP-4746863-A1 | ENDOXIFEN COMPOSITIONS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF | Atossa Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122081244-A | Novel methicillin-resistant staphylococcus aureus phage and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| US-20260137637-A1 | ANESTHETIC AGENT MICRO AND NANO PARTICLES, AND METHODS OF MAKING AND USING THE SAME | HAAS ERIC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137650-A1 | MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) | 11949098 CANADA INC (CA) | 2026-05-21 | — | — | US | claimed |
| EP-4136079-B1 | BENZIMIDAZOLE COMPOUND FOR THE TREATMENT OF METABOLIC DISORDERS | ACHE LABORATORIOS FARMACEUTICOS SA (BR) | 2026-05-20 | — | — | EP | claimed |
| EP-4743098-A1 | THERAPEUTIC USE OF FIBROBLASTS FOR THE TREATMENT OF PSORIASIS | FibroBiologics, Inc. (US) | 2026-05-20 | — | — | EP | claimed |
| US-12629360-B2 | Ophthalmic composition | Sydnexis, Inc. (US) | 2026-05-19 | — | — | US | claimed |
| WO-2026099533-A1 | TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH GPBP1 INHIBITORS | UNIVERSITAT DE VALÈNCIA (ES) | 2026-05-15 | — | — | WO | claimed |
| US-3993642-A | Penicillins | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-23 | — | — | US | claimed |
| US-3988327-A | 7-(α-SULFOACYLAMIDO)CEPHALOSPORANIC ACIDS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-10-26 | — | — | US | claimed |
| US-3982011-A | ANTIBIOTICS, ANIMAL GROWTH PROMOTERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-09-21 | — | — | US | claimed |
| US-3974288-A | ANTIBACTERIAL ACTIVITY | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | claimed |
| US-3957980-A | INJECTABLE ANTIBIOTICS | PFIZER INC. (US) | 1976-05-18 | — | — | US | claimed |
| US-3944544-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1976-03-16 | — | — | US | claimed |
| US-3944546-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1976-03-16 | — | — | US | claimed |
| US-3932396-A | ANTIBIOTICS | E. R. SQUIBB & SONS, INC. (US) | 1976-01-13 | — | — | US | claimed |
| US-3932397-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1976-01-13 | — | — | US | claimed |
| US-3931153-A | BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | claimed |